Could stem cells beat standard care for arthritic knees?
NCT ID NCT07542808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single injection of StromaForte, made from donor bone marrow cells, against a standard hyaluronic acid injection for knee osteoarthritis. About 140 adults with knee arthritis will receive one treatment and be followed for 12 months. The main goal is to see if StromaForte provides better pain relief during activity at 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE ARTHRITIS OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Burjeel Medical City
RECRUITINGAbu Dhabi, United Arab Emirates
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can education boost exercise compliance for chronic pain sufferers?
- Could a simple X-Ray measurement outperform BMI in knee surgery safety?
- Can sound waves soothe aching knees?
- Can specialized exercise ease knee arthritis disability?
- Can a simple pressure-sensing device beat foam rolling for knee arthritis pain?
- Could a simple knee sleeve slow arthritis and ease pain?